Trending Now
Jaguar Health Inc (NASDAQ:JAGX) Posts A Growth Of 186% YoY In...
Jaguar Health Inc (NASDAQ:JAGX) reported revenues of $6.3 million in Q2 2020. Mytesi contributed net revenues of $3.2 million in Q2 2020. The number...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
SPY ready to draw blood on Wall Street
Looks like the bull rally on SPY is finally going to come to an end today. We saw a pullback this weekend...
MAKE IT MODERN
LATEST REVIEWS
VistaGen Therapeutics Inc. (NASDAQ: VTGN) Commences Phase 2A Study Evaluating PH94B...
VistaGen Therapeutics Inc. (NASDAQ: VTGN) has announced the commencement of phase 2A clinical study to assess safety, tolerability, and efficacy of PH94B as a...
MAKE IT MODERN
PERFORMANCE TRAINING
Financial markets do not seem to be stressed (DIS, CAR, K)
The market gapped down this morning in continued risk-off sentiment although there has been a small pop on the open. The QQQ’s...
Viking Therapeutics (VKTX): Is This Weight Loss Drug Contender Worth Buying on the Dip?
Viking Therapeutics (NASDAQ: VKTX) has made significant waves in the biotechnology sector this year, emerging as a formidable contender in the booming...
Verona Pharma PLC (VRNA) Hits All-Time High Amid COPD Treatment Breakthrough and Strategic Advances
Verona Pharma PLC (NASDAQ: VRNA), a trailblazer in respiratory disease treatments, is currently riding a wave of success, having reached an all-time...
The Human Research Ethics Committee of Monash Health Grants an Approval to Mesoblast Limited...
Throughout its many years of operation, Mesoblast Limited (NASDAQ:MESO) has established a culture of creating clinically differentiated products. The use of a proprietary technology...
Applied DNA Sciences Inc. (NASDAQ: APDN): Expanding Horizons in DNA Technology and Clinical Testing
Applied DNA Sciences Inc. (NASDAQ: APDN), a leader in PCR-based DNA technologies, has once again made headlines with a significant development in...
MAKE IT MODERN
